PROF. DR. PAOLO POZZILLI

Professor of Diabetes and Clinical Research at the Centre for Diabetes at Barts and The London School of Medicine & Dentistry, London, and Professor of Endocrinology & Metabolic Diseases at the University Campus Bio-Medico in Rome, Italy.

Professor Paolo Pozzilli, MD, trained in Medicine and specialized in Endocrinology & Metabolic Diseases at Sapienza University of Rome, Italy. He is Professor of Endocrinology and Diabetes at Campus Bio-Medico University of Rome (UCBM) and Professor of Clinical Research (Diabetes) at the Centre of Immunobiology,
Blizard Institute, Barts and the London School of Medicine and Dentistry.
His main research interest is in the field of pathogenesis and prevention of type 1 diabetes (T1D) from basic studies on the disease’s autoimmune mechanisms to clinical trials testing novel therapies. Most relevant international clinical studies he participated as Leader or regional P.I. include ENDIT, TRIGR, ROADMAP, ELIXA, DEFEND, GAD Alum, Action LADA, and more recently EMPAREG, EXSCEL, CANVAS and inTANDEM3 trials. He is deputy leader of the Action LADA (Latent Autoimmune Diabetes in Adults) project funded by the EU and the coordinator of a joint international PhD programme in Integrated Biomedical Sciences and Bioethics between UCBM and QMUL. He is Editor in Chief of Diabetes Metabolism Research & Reviews.
He has received several Awards including the Andrew Cudworth Memorial Award by the British Diabetic Association, the Morgagni Award for Best Young Investigator by the International Society of Metabolism, the Prize by the Italian Society of Diabetes, the Marie Kugel Award by the Juvenile Diabetes Foundation, the Diabetes Honoris Causa by the Paulescu Foundation, the Celso Prize by the Italian Society of Diabetes and the Menarini Award, Joseph Hoet Memorial Lecture by the World Foundation on Diabetes Prevention (2016). He published 515 papers (Pubmed).